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Abstract 
 
Nitro-fatty acids are electrophilic fatty acids produced in vivo from nitrogen peroxide that 
have many physiological activities. We recently demonstrated that nitro-fatty acids activate 
the Keap1-Nrf2 system, which protects cells from damage due to electrophilic or oxidative 
stresses via transactivating an array of cytoprotective genes, although the molecular 
mechanism how they activate Nrf2 is unclear. A number of chemical compounds with 
different structures have been reported to activate the Keap1-Nrf2 system, which can be 
categorized into at least six classes based on their sensing pathways. In this study, we showed 
that nitro-oleic acid (OA-NO2), one of major nitro-fatty acids, activates Nrf2 in the same 
manner that of a cyclopentenone prostaglandin 15-deoxy-∆12,14-prostaglandin J2 (15d-PGJ2) 
using transgenic zebrafish that expresses green fluorescent protein (GFP) in response to Nrf2 
activators. In transgenic embryos, GFP was induced in the whole body by treatment with 
OA-NO2, 15d-PGJ2 or diethylmaleate (DEM), but not with hydrogen peroxide (H2O2), when 
exogenous Nrf2 and Keap1 were co-overexpressed. Induction by OA-NO2 or 15d-PGJ2 but 
not DEM was observed, even when a C151S mutation was introduced in Keap1. Our results 
support the contention that OA-NO2 and 15d-PGJ2 share an analogous cysteine code as 
electrophiles and also have similar anti-inflammatory roles. 
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Introduction 
 
The Keap1-Nrf2 system plays a central role in the cellular defense against electrophilic and 
oxidative stresses by orchestrating gene expression of detoxifying and antioxidant enzymes 
(Kobayashi & Yamamoto 2006; Kensler & Wakabayashi 2010). Nrf2 is a transcription factor that 
heterodimerizes with small Maf proteins and binds to the antioxidant responsive element (ARE)/ 
electrophile responsive element (EpRE) within the regulatory region of its target genes. Keap1 is a 
substrate-specific adaptor protein for a Cul3-dependent E3 ubiquitin ligase complex that 
homodimerizes and interacts with the ETGE and DLG motifs of Nrf2. Under basal conditions, Nrf2 
is maintained at low levels due to Keap1-dependent ubiquitination and proteasomal degradation. 
Upon exposure to electrophiles or oxidative stress, Nrf2 is stabilized and accumulates in the nucleus, 
where it transactivates ARE/EpRE-regulated genes.  
   A variety of Nrf2 activators have been reported (Kobayashi & Yamamoto 2005). Some of these 
activators have protective activities against carcinogenesis, neuronal damage and inflammation that 
can be ingested as dietary agents for the prevention and therapy of age-related diseases such as 
cancer, cardiovascular diseases, chronic inflammation, and neurodegenerative diseases (Calabrese 
et al. 2008). On the other hand, positive roles of Nrf2 in cancer tumorigenesis and chemoresistance 
have recently been uncovered (Hayes & McMahon 2009; Lau et al. 2008). It will be important to 
understand the differences between the Nrf2 activators, in particular the mechanisms of Keap1-Nrf2 
activation, the activation of other systems, and which Nrf2-target genes they induce.  
   The new field has focused on the identification of sensor molecules that activate Nrf2. These 
activators have a common ability to modify sulfhydryl groups by alkylation, oxidation, or reduction. 
This observation suggests that cells possess a primary sensor for Nrf2 activators that is equipped 
with highly reactive cysteine residues. Cys-151 of mouse Keap1 is a target site for many Nrf2 
activators such as DEM (Kobayashi et al. 2009; Sekhar et al. 2010). We recently found that 
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cyclopentenone prostaglandins, 15d-PGJ2 and prostaglandin A2 (PGA2), target residues other than 
Cys-151 in Keap1, perhaps Cys-273 (Kobayashi et al. 2009). Furthermore, sensor proteins for H2O2, 
cadmium chloride, and gold-compound auranofin were not Keap1 or Nrf2 (Kobayashi et al. 2009). 
The target selections of a variety of Nrf2 activators should be investigated comprehensively.  
   The Keap1-Nrf2 system is conserved among vertebrates, including zebrafish (Kobayashi et al. 
2002; Takagi et al. 2004; Li et al. 2008). Among the known endogenous targets of zebrafish Nrf2, 
the pi-class glutathione S-transferase 1 gene (gstp1) showed the strongest induction in both 
electrophile-treated larvae and Nrf2-overexpressing embryos. The gene regulatory region of gstp1 
was examined by a GFP reporter gene analysis using microinjection into zebrafish embryos, and an 
ARE/EpRE-like sequence located 30 bp upstream of the transcription initiation site was shown to 
be necessary and sufficient for the induction by Nrf2 (Suzuki et al. 2005).  
   In this study, we tried to generate stable transgenic zebrafish lines that express GFP in response 
to Nrf2 activators using a 3.5 kb gene regulatory region of gstp1 to develop a rapid and easy 
method for screening and classifying Nrf2 activators. Two stable transgenic lines that express GFP 
in the larval olfactory regions in response to Nrf2 activators were isolated. No GFP induction was 
detected in transgenic embryos, but strong induction in response to DEM and 15d-PGJ2, but not 
H2O2, was observed when both Nrf2 and Keap1 were overexpressed. Using this system, we 
classified a newly identified Nrf2 activator, OA-NO2, into the same category as 15d-PGJ2. 
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Results 
 
Generation of stable transgenic lines that express GFP in response to Nrf2 activators 
In transient assays, GFP expression from the p3.5gstp1GFP construct which contains a 3.5 kb 
promoter region of the zebrafish gstp1 gene is strongly transactivated by Nrf2 in zebrafish embryos 
(Fig. 1A; Suzuki et al. 2005). Stable transgenic lines carrying this construct were isolated by 
genotyping F1 embryos from p3.5gstp1GFP-injected founders. Although three stable lines were 
isolated, none of the three lines exhibited GFP expression upon treatment with DEM, thus 
suggesting a position effect of the transgene (data not shown; Table S1 in Supporting Information). 
To circumvent this problem, a highly efficient Tol2 transposon system (Kawakami et al. 2004) was 
used to generate additional stable lines. A pT3.5gstp1GFP construct was made by introducing Tol2 
sequences into p3.5gstp1GFP and were co-injected into zebrafish embryos with mRNA encoding 
Tol2-specific transposase. Injected founders (n=104) were raised and 12 transgenic lines, which 
showed GFP expression in F1 larvae, were isolated (Table S1 in Supporting Information). Out of 12 
Tg(-3.5gstp1:GFP) lines, two lines exhibited GFP induction in response to DEM, and the rest 
displayed only basal GFP expression. In the larvae of these two lines (it416a and it416b), strong 
GFP induction was observed in the olfactory regions as for endogenous gstp1, while constitutive 
GFP expression was also detected in the lens, ears, fins, pericardium, and lateral lines (Figs. S1 and 
S2 in Supporting Information). We used the it416b line for further experiments because it exhibited 
stronger GFP induction than the it416a line. 
   In day 4 larvae, induction of endogenous gstp1 expression began approximately 3 hours after 
DEM treatment and reached maximum expression levels around 6 to 9 hours (data not shown). GFP 
induction in the olfactory regions of Tg(-3.5gstp1:GFP)it416b larvae was first detected at 6 hours 
after DEM treatment and later became stronger (Fig. 1B; Movie S1 in Supporting Information). 
This induction was greatly reduced when nrf2 was knocked down with the nrf2-specific 
T. Tsujita et al. 
6 
antisense-morpholino oligonucleotide (nrf2MO) (Kobayashi et al. 2002), suggesting that GFP 
induction was mediated by Nrf2 (Fig. 1C). 
 
Quantification of GFP induction 
To quantify the level of the GFP expression, a fluorescent intensity in the olfactory regions was 
measured using an imaging analyzer equipped with the BZ-8000 microscope (Keyence) (Fig. 2A). 
The average fluorescent intensities of DEM-induced GFP expression in the olfactory regions were 
measured using 3, 10, or 30 individual larvae, and all of these showed similar values (Fig. 2B). We 
therefore used three individuals for quantification of the GFP induction in further analyses. 
According to this quantification, the reduction of DEM-induced GFP expression by the 
nrf2-knockdown was calculated as one-third (Fig. 2C).  
   We first quantified the time- and dose-dependencies of DEM-induced GFP expression. GFP 
expression in the olfactory regions of Tg(-3.5gstp1:GFP)it416b larvae treated with various DEM 
concentrations was measured at 3, 6, 10 and 14 hours following treatment (Fig. 2D). GFP induction 
is detectable with treatment over 30 µM DEM, which is similar for detecting endogenous gstp1 
induction by a real-time reverse transcription (RT)-PCR examination (Fig. 2E) or by a 
whole-mount in situ hybridization (data not shown). The onset of GFP induction (6 h) was later 
than that of endogenous gstp1 induction (3 h), most likely due to the time required for the 
accumulation of GFP protein. Altogether, these results suggest that the measurement sensitivity of 
DEM-induced GFP expression using the fluorescence intensities in the olfactory regions is 
comparable to that of endogenous gstp1 induction in the whole body using a real time RT-PCR 
analysis. 
 
Quantification of reduced GFP induction in the it567 mutant larvae 
We have screened and isolated zebrafish mutants that have defects in gstp1 induction by Nrf2 
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activators (Kobayashi et al. 2009). One of these mutants, it567, has reduced induction of gstp1 in 
response to DEM. To visualize this reduction in living larvae, we crossed it567 fish with 
Tg(-3.5gstp1:GFP)it416b fish. As expected, DEM-induced GFP expression in the olfactory regions 
of it567 homozygous larvae was significantly reduced compared to that of sibling wild-type larvae 
(Fig. 3; Movie S2 in Supporting Information). The result indicates that homozygous mutant larvae 
are easily distinguishable from wild-type siblings by monitoring GFP induction upon treatment with 
DEM, although we have not identified the gene responsible for the it567 mutation.  
 
GFP induction by a variety of Nrf2 activators  
To elucidate whether Tg(-3.5gstp1:GFP)it416b can monitor the induction by a variety of Nrf2 
activators, five Nrf2-activating compounds in different classes were examined (Kobayashi et al. 
2009). Day 4 larvae of Tg(-3.5gstp1:GFP)it416b fish were treated with sulforaphane, 15d-PGJ2, 
H2O2, auranofin or CdCl2, and the GFP expression in the olfactory regions was monitored in three 
individuals (Fig. 4A). GFP induction was observed in larvae treated with all tested Nrf2 activators, 
although it was a bit weaker upon induction with H2O2 and CdCl2. The results suggest that 
Tg(-3.5gstp1:GFP)it416b can be used for the analysis of Nrf2 activator sensing mechanisms and 
also to screen for novel and unidentified activators. 
   We recently classified eleven Nrf2 activators based on the requirement of these activators for an 
Nrf2 response (Kobayashi et al. 2009). The classification was carried out using zebrafish embryos 
overexpressing Nrf2 and Keap1. The embryos were treated with each Nrf2 activator and the 
induction of the endogenous gstp1 gene was analyzed by a whole-mount in situ hybridization or by 
an RT-PCR analysis. It will be time- and labor-saving if Tg(-3.5gstp1:GFP)it416b can be utilized 
for this analysis. To test this possibility, Nrf2 was overexpressed by an mRNA injection in embryos 
obtained from crossing heterozygous transgenic males and non-transgenic females and GFP 
expression was analyzed during gastrulation stages (Fig. S3 in Supporting Information). Robust 
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GFP expression was observed in the embryos injected with Nrf2 mRNA, while no GFP expression 
was observed in uninjected embryos.  
   We then generated homozygous transgenic lines to make all the injected embryos positive for 
GFP. Embryos obtained from homozygous transgenic males and non-transgenic females were used 
for the further analyses, because maternal GFP expression was observed in embryos derived from 
transgenic females (data not shown). When wild-type or C151S mutant Keap1 was overexpressed 
with Nrf2, no GFP expression was observed, indicating that Keap1 suppressed GFP inducing 
activity of Nrf2 (Fig. 4B). Treatment of DEM cancelled the Nrf2-suppression by wild-type Keap1 
but not by C151S Keap1, while 15d-PGJ2 released Nrf2 activity from both. H2O2 treatment had no 
effect at all. These results suggest that Keap1 is a sensor for DEM and 15d-PGJ2, but not for H2O2, 
and Cys-151 is required for DEM but not 15d-PGJ2 sensing. All these results were identical as in 
the case of the previous analyses conducted using endogenous gstp1 induction (Kobayashi et al. 
2009). 
 
OA-NO2 activates Nrf2 as 15d-PGJ2 
OA-NO2 was next analyzed as an uncharacterized Nrf2 activator using Tg(-3.5gstp1:GFP)it416b. 
OA-NO2 is a nitro-fatty acid that has been recently shown to activate Nrf2 (Freeman et al. 2008). 
Nitro-fatty acids are electrophilic fatty acids produced in vivo from nitrogen peroxide that have 
many physiological activities, such as cGMP-dependent vessel relaxation, the inhibition of the 
inflammatory cell function, the induction of heme oxygenase 1 expression, the inhibition of NFκB, 
peroxisome proliferator-activated receptor (PPAR) activation, and Nrf2 activation. GFP expression 
in the olfactory regions of Tg(-3.5gstp1:GFP)it416b larvae was analyzed after treatment with 
OA-NO2 at 4 days post-fertilization (dpf) (Fig. 5A,B). A significant GFP induction was observed in 
the olfactory regions of OA-NO2-treated larvae and was decreased upon Nrf2 knockdown after 
injecting nrf2MO. GFP induction was also observed with OA-NO2 treatment of embryos 
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overexpressing Nrf2 and Keap1 (Fig. 5C). Significantly, the Keap1 C151S mutation could not 
eliminate this induction, suggesting that Cys-151 is not a sensing site for OA-NO2 in the 
Keap1-Nrf2 system. Identical results were obtained when the induction of endogenous gstp1 was 
analyzed by RT-PCR (Fig. 5D). We also showed that a Cys-to-Ser mutation in Cys-288, another key 
reactive cysteine in Keap1, had no effect on the response to OA-NO2 (Fig. S4 in Supporting 
Information). It must be noted that these are same results as in the case of 15d-PGJ2 (Kobayashi et 
al. 2009). 
   To determine the sites in Keap1 modified by OA-NO2, mouse Keap1 protein treated with or 
without OA-NO2 was digested with trypsin and analyzed by matrix-assisted laser desorption 
ionization time-of-flight mass spectrometry (MALDI-TOF MS). Peptide mass mapping by an 
MALDI-TOF MS analysis of the trypsin fragments of native mouse Keap1 made it possible to 
identify the peptides, thus accounting for ~80% of the protein sequence (see Table S2 in the 
Supporting Information). Compared with the calculated masses of the unmodified peptides, 
modified peptides P-1 to P-6 had an increased mass of +327.4 Da, thus corresponding to the 
addition of a single equivalent of OA-NO2 (Fig. 6). The sequences and masses of the peptides were: 
P-1 (CHALTPR, m/z = 1124.8), P-2 (SGVGVAVTMEPCR, m/z = 1632.7), P-3 (LNSAECYYPER, 
m/z = 1671.7), P-4 (LSQQLCDVTLQVK, m/z = 1802.1), P-5 (SGLAGCVVGGLLYAVGGR, m/z = 
1976.2), and P-6 (QEEFFNLSHCQLATLISR, m/z = 2463.3), indicating that mouse Keap1 is 
modified by OA-NO2 at Cys-77, Cys-226, Cys-273, Cys-368, Cys-489 and Cys-613. It should be 
noted that Cys-273 was included in the amino acids to which 15d-PGJ2 and PGA2 were shown to 
bind in our previous analyses (Fig. 6B; Kobayashi et al. 2009). 
   Another criterion of the classification is dependency to it275 gene. it275 is a zebrafish mutant 
which has defects in the response to some, but not all, Nrf2 activators. For example, induction of 
endogenous gstp1 was decreased in it275 larvae in response to 15d-PGJ2, auranofin and CdCl2, and 
was similar with wild-type larvae in response to DEM, sulforaphane and H2O2. gstp1 expression 
T. Tsujita et al. 
10 
was analyzed in it275 larvae or sibling wild-type larvae with or without OA-NO2 treatment at 4 dpf 
by an in situ hybridization (Fig. 7). OA-NO2-dependent gstp1 induction in gills or olfactory regions 
was dramatically reduced in it275 larvae compared to wild-type larvae. The reduction was not 
observed in larvae treated with DEM. This result suggests that Nrf2 activation mediated by 
OA-NO2 requires the it275 gene, which is also similar to 15d-PGJ2.  
   Taken together, OA-NO2 was classified as a class 4 Nrf2 activator, as are 15d-PGJ2 and PGA2 
(Kobayashi et al. 2009). We thus hypothesize that nitro-fatty acids and cyclopentenone 
prostaglandins share strategies to activate the Keap1-Nrf2 system. 
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Discussion 
 
We previously demonstrated that nitrolinoleic acid (LNO2), a nitro-fatty acid similar to OA-NO2, 
also activates Nrf2 in cultured cells (Villacorta et al. 2007). The present study verifies that 
nitro-fatty acids are indeed effective Nrf2 activators in living animals. The covalent binding of 
OA-NO2 with reactive cysteines and histidines has been demonstrated previously in a variety of 
proteins (Batthyany et al. 2006). It is quite possible that OA-NO2 directly binds Keap1, most likely 
at Cys-273. Importantly, OA-NO2 appears to belong to the same Nrf2 activator class as 15d-PGJ2 as 
we have described herein. Strikingly the chemical structures of nitro-fatty acids (OA-NO2 and 
LNO2) and cyclopentenone prostaglandins (15d-PGJ2 and PGA2) are similar (Fig. 7A). We 
speculate that unique structures common between these compounds are essential for targeting 
identical sites in the Keap1 protein. Besides activating Nrf2, nitro-fatty acids can activate PPARγ as 
an endogenous ligand with covalent binding to Cys-285 (Schopfer et al. 2005; 2010), and can 
inhibit NFκB-DNA binding through direct interaction with p65 (Cui et al. 2006). Interestingly, 
15d-PGJ2 also exhibits these properties via direct binding to PPARγ at Cys-285 (Shiraki et al. 2006) 
and p65 of NFκB at Cys-38 (Straus et al. 2000). It is plausible that OA-NO2 can also bind to 
Cys-38 of NFκB p65. We hypothesize that electrophilic signaling compounds, such as nitro-fatty 
acids and cyclopentenone prostaglandins, can bind to a series of key target proteins (e.g., Keap1, 
PPARγ and NFκB) and thereby exert their physiological functions (for example, anti-inflammatory 
effects) by the combined actions of their target proteins (Fig. 7B) (the cysteine code hypothesis, 
Kobayashi et al. 2009). 
   The Tg(-3.5gstp1:GFP)it416b line established in the current study can monitor 
electrophile-induced gene expression in vivo and will be useful for many situations, for example in 
gene analyses, small molecule screens, and mutant fish screens. Generation of real-time monitoring 
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systems of electrophile-induced Nrf2 activation has been studied for many years. Stable cell lines 
that can monitor Nrf2 activation were previously produced using multiple ARE/EpRE sequences as 
transcriptional drivers and GFP or luciferase as reporter genes (Zhu & Fahl 2001; Wang et al. 2006). 
The results obtained by use of these cell lines are reproducible and are more reliable than 
experiments relying on transient transfection. Transgenic mice which have luciferase reporter genes 
fused to multiple ARE/EpRE sequences were also generated (Yates et al. 2007; Fisher et al. 2007). 
These transgenic mice are useful since they can allow the monitoring of tissue- and developmental 
stage-specific profiles of Nrf2 activation. Real-time activation of Nrf2 in disease models can also be 
analyzed by crossing these mice with a variety of gene-disrupted mice. However, this model has 
shortcomings, in that administration of the substrate luciferin into mice is required, whose 
disposition and side-effects may affect the proper analysis of results. The use of GFP instead of 
luciferase will be helpful to overcome this problem: however, it is difficult to analyze GFP 
expression in the internal regions of a mouse. Trials to generate stable transgenic zebrafish that 
harbor ARE/EpRE-driven GFP reporter gene have been carried out (Carvan et al. 2000; Kusik et al. 
2008) but were unsuccessful. Tg(-3.5gstp1:GFP)it416b is the first ARE/EpRE-GFP reporter line 
that can be used to monitor Nrf2 activation at a practical and physiologically relevant level. Our 
success was due to a screen of effective lines from substantial numbers of stable transgenic lines. In 
that sense, the use of the Tol2 transposon system was an important strategy which greatly improved 
the transgene integration efficiency (Kawakami 2007). 
   At the onset of this study, we hoped to establish transgenic lines that can analyze tissue-specific 
differences in GFP induction upon induction by a variety of Nrf2 activators. Unfortunately, this 
method did not succeed. GFP induction in gills and livers, in which endogenous gstp1 was induced 
(in addition to the olfactory regions), was not observed in the present lines. We supposed that cis- 
and trans-activating factors required for gstp1 induction differ between tissues. Indeed, cell-specific 
differences in the induction levels of the ARE/EpRE-reporter gene have been demonstrated using 
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cultured cell lines (Wang et al. 2006). Gene regulatory elements required for the expression in gills 
and liver other than ARE/EpRE sequences may not be included in the 3.5-kb gstp1 region. The 
negative and positive roles of Nrf2 in human health have both been recently demonstrated (Hayes & 
McMahon 2009; Lau et al. 2008). It will be important to elucidate the molecular mechanisms of the 
cell-specific induction of Nrf2 target genes, particularly in cancer cells. Modified bacterial artificial 
chromosomes for transgenesis will be useful to identify cis-activating factors for cell specificity 
(Yang et al. 2009). 
   The zebrafish is an attractive model for analyzing gene expression profiles since it has 
transparent embryos and larvae. Moreover, a transparent adult line, termed casper, has been 
recently generated (White et al. 2008). Thus, utilizing a GFP reporter will facilitate the visualization 
of a variety of stress responses in living animals. Indeed, cellular responses to metals, such as 
cadmium, copper, and arsenate, were monitored in GFP transgenic zebrafish using heat shock 
promoters (Blechinger et al. 2007; Wu et al. 2008; Seok et al. 2007). GFP induction by 
environmental estrogens and dioxin was also analyzed by GFP transgenic zebrafish using estrogen 
response elements + vitellogenin promoter (Chen et al. 2010) and cytochrome P4501A1 promoter 
(Mattingly et al. 2001), respectively, as transcriptional drivers. The zebrafish provides opportunities 
to accelerate the process of drug discovery (Zon & Peterson 2005). These GFP transgenic lines, 
including Tg(-3.5gspt1:GFP)it416b, will contribute to several aspects of the drug development 
process, including target identification by genetic and morpholino-oligonucleotide screens, lead 
discovery by small-molecule screens, and the testing of drug efficacy and toxicity. The application 
of Tg(-3.5gspt1:GFP)it416b to screen novel Nrf2 activators and inhibitors will be therefore be 
pursued in future studies. 
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Experimental procedures 
 
Zebrafish 
Embryos and larvae were obtained by natural mating. The wild-type strain AB and the mutant strain 
it567 (Kobayashi et al. 2009) were used. The stable transgenic lines Tg(-3.5gstp1:GFP)it416a and 
Tg(-3.5gstp1:GFP)it416b were maintained as homozygous lines. Homozygous transgenic lines 
were crossed with the AB strain to obtain embryos and larvae for experiments. The genotyping of 
transgenic lines was performed by PCR using genomic DNA as templates and the primers 5’- 
CCTCGTGACCACCCTGAC-3’ and 5’- TGGCGGATCTTGAAGTTCAC-3’.  
   The transgenic line, Tg(-3.5gstp1:GFP)it416b, can be obtained upon request under the support 
of Zebrafish National Bioresource Project of Japan 
(http://www.shigen.nig.ac.jp/zebra/index_en.html). 
 
Chemical Treatments 
For the induction studies, zebraﬁsh were placed in culture dishes containing 100  µM DEM (Wako, 
Osaka, Japan), 40 µM sulforaphane (LKT laboratories, St. Paul, MN), 2.5 µM 15d-PGJ2 (Cayman 
Chemical, Ann Arbor, MI), 1 µM auranofin (Enzo Life Sciences, Farmingdale, NY), 1 mM H2O2 
(Wako), 20 µM CdCl2 (Wako) and 1.5 or 2.5 µM OA-NO2. OA-NO2 was prepared as previously 
described (Baker et al. 2005). 
  
Plasmids 
pT3.5gstp1GFP was generated by replacing the Xenopus EF1α enhancer/promoter region in 
pT2KXIG (Kawakami et al. 2004) with a XhoI-NotI fragment of p3.5gstp1GFP (Suzuki et al. 2005). 
The construct was verified by DNA sequencing. Plasmids pCS2nrf2, pCS2FLmKeap1, 
pCS2FLmKeap1C151S, pCS2FLmKeap1C288S, pKSgstp1N, and pCS-TP were described 
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previously (Kobayashi et al. 2002; 2009; Kawakami et al. 2004). 
 
Microinjection 
For the overexpression of Nrf2 and Keap1 proteins, synthetic capped mRNA was generated with an 
SP6 mMESSAGE mMACHINE in vitro transcription kit (Ambion, Austin, TX) using linearized 
DNA of the pCS2 derivatives described above and injected into yolk at the one-cell stage using an 
IM300 microinjector (Narishige, Tokyo, Japan). For knocking-down zebrafish Nrf2 (nrf2), 
antisense morpholino-oligonucleotides (Gene Tools, Philomath, OR) specific for nrf2 (nrf2MO) 
(Kobayashi et al. 2002) were injected into yolk at the one-cell stage. For generating stable 
transgenic lines, 25 pg of pT3.5gstp1GFP or p3.5gstpGFP was co-injected into a blastomere of 
early one-cell stage embryos with 25 pg of Tol2-transposase mRNA synthesized from 
NotI-linearized pCS-TP as previously described (Takeuchi et al. 2010).  
 
Expression Analysis 
GFP expression during various embryonic stages was examined under a GFP2 (480 nm excitation, 
510 nm barrier) filter of a MZFLIII microscope (Leica, Wetzler, Germany) equipped with a 
600CL-CU digital camera (Pixera Los Galos, CA). GFP expression during larval stages was 
analyzed under a GFP-BP BZ filter (470 nm excitation, 535 nm emission) of a Biozero BZ-8000 
microscope (Keyence, Osaka, Japan). For taking time-lapse photographs, larvae were anesthetized 
with 0.016% 3-aminobenzoic acid ethyl ester (Sigma-Aldrich, St. Louis, MO) and placed on a hole 
slide glass containing 3% methylcellulose (Sigma Aldrich) for immobilization. To quantify GFP 
expression, fluorescence intensity in the olfactory regions was measured by an image processing 
system equipped with the BZ-8000 microscope. The gene expressions of endogenous gstp1 were 
examined by an in situ hybridization analysis, a RT-PCR analysis, or a real-time RT-PCR analysis, 
as previously described (Li et al. 2008; Kobayashi et al. 2001). 
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MALDI-TOF MS analysis. The recombinant mouse Keap1 protein expressed by E. coli was 
incubated with or without 100 µM OA-NO2 for 60 min at 25°C in buffer containing 20 mM 
Tris-HCl, pH 8.5. The trypsin-digested mouse Keap1 was mixed with dithiothreitol and 
trifluoroacetic acid. To improve the ionization efficiency of MS, samples were purified with Zip-tip 
µC18 (Millipore, Bedford, MA) before MS analysis. Peptides were mixed with 
α-cyano-4-hydroxycinnamic acid (2.5 mg/ml) containing 50% acetonitrile and 0.1% trifluoroacetic 
acid and dried on stainless steel targets at room temperature. The analyses were performed using an 
AXIMA-TOF2 (Shimadzu, Tokyo, Japan) with a nitrogen laser. All analyses took place in the 
positive ion mode and the instrument was calibrated immediately prior to each series of studies. 
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Figure Legends 
 
Figure 1 DEM-induced GFP expression in Tg(-3.5gstp1:GFP)it416b larvae. (A) A schematic 
diagram of the p3.5gstp1GFP construct. Ex1 and ExII denote exon 1 and exon 2, respectively, of 
the gstp1 gene. (B) Time-course of GFP expression in the olfactory regions (arrowheads) of 
Tg(-3.5gstp1:GFP)it416b larvae at 4 dpf after treatment with 100 µM DEM. The asterisks and 
arrows denote the constitutive GFP expression in the lens and lateral lines, respectively. Dorsal 
views. (C) Effects of nrf2 knockdown on DEM-induced GFP expression. Day 4 larvae of the 
Tg(-3.5gstp1:GFP)it416b line injected with nrf2MO at the one-cell stage were treated with 100 µM 
DEM treatment for 12 hours. 
 
Figure 2 Quantification of DEM-induced GFP expression. (A) Fluorescence intensities in the areas 
enclosed by the triangles were analyzed. (B) Determination of sample numbers. The indicated 
numbers of Tg(-3.5gstp1:GFP)it416b larvae were treated with 100 µM DEM for 12 hours at 4 dpf, 
and the average fluorescence intensities in the olfactory regions were calculated. Error bars indicate 
standard deviation values. (C) The effects of nrf2 knockdown on 100 µM DEM-induced GFP 
expression at 4 dpf. The average fluorescence intensities in the olfactory regions of three individual 
Tg(-3.5gstp1:GFP)it416b larvae were analyzed: larvae were injected with or without nrf2MO at the 
one-cell embryo stage. (D) Time- and dose-effects on DEM-induced GFP expression at 4 dpf. The 
average fluorescence intensities in the olfactory regions of three individual 
Tg(-3.5gstp1:GFP)it416b larvae were analyzed. (E) Real time RT-PCR analysis. Time- and 
dose-dependent effects on DEM-induced expression of endogenous gstp1 at 4 dpf.  
 
Figure 3 Effect of the it567 mutation on DEM-induced GFP expression. (A) GFP expression in the 
it567 mutant larvae at 4 dpf. Tg(-3.5gstp1:GFP)it416b;it567/it567 larvae or wild-type siblings were 
treated with 100 µM DEM for 6 hours. Arrowheads indicate the olfactory regions. (B) Average 
fluorescence intensities of three individual larvae were analyzed. Error bars indicate the standard 
deviation values.  
 
Figure 4 GFP induction by a variety of Nrf2 activators. (A) GFP induction in the olfactory regions 
of Tg(-3.5gstp1:GFP)it416b larvae at 4 dpf by sulforaphane (SF), 15d-PGJ2, H2O2, auranofin (AF), 
and CdCl2. Ctr denotes non-treated control larvae. Error bars indicate the standard deviation values 
of three individual larvae. (B) GFP induction in Tg(-3.5gstp1:GFP)it416b embryos by DEM, 
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15d-PGJ2 and H2O2. Tg(-3.5gstp1:GFP)it416b embryos co-injected with wild-type (WT) or C151S 
Keap1 mRNA and Nrf2 mRNA were treated with Nrf2 activators for 6 hours. 
 
Figure 5 OA-NO2 induced GFP expression in Tg(-3.5gstp1:GFP)it416b larvae and embryos. (A, 
B) GFP induction by 1.5 µM OA-NO2 in the olfactory regions (arrowheads) of 
Tg(-3.5gstp1:GFP)it416b larvae at 4 dpf. The effects of Nrf2 knockdown were analyzed using 
nrf2MO. Error bars indicate the standard deviation values of three individual larvae. (C) OA-NO2 
induced GFP expression in Tg(-3.5gstp1:GFP)it416b embryos. Tg(-3.5gstp1:GFP)it416b embryos 
were co-injected with wild-type (WT) or C151S Keap1 mRNA and Nrf2 mRNA were treated with 
2.5 µM OA-NO2 for 6 hours. (D) An RT-PCR analysis of OA-NO2–induced endogenous gstp1 
expression. Embryos co-injected with wild-type (WT) or C151S Keap1 mRNA and Nrf2 mRNA 
were treated with 2.5 µM OA-NO2 for 6 hours.  
 
Figure 6 Identification of the sensor cysteines for OA-NO2. (A) MS analysis of peptides from 
mouse Keap1 digested with trypsin following incubation with of without OA-NO2. Mouse Keap1 
(3 µg) was incubated at 25˚ C for 60 minutes in the absence (top) or presence (bottom) of 100 µM 
OA-NO2 in a total volume of 10 µl containing 20 mM Tris-HCl (pH8.5). (B) Modification sites in 
mouse Keap1 for Nrf2-activating compounds was determined by MS analysis. The modification 
sites for 15d-PGJ2 and PGA2 have been analyzed previously (Kobayashi et al. 2009).  
 
Figure 7 Effect of the it275 mutation on OA-NO2-induced endogenous gstp1 expression. An in situ 
hybridization analysis of endogenous gstp1 expression (arrowheads) of homozygous it275 larvae 
and wild-type siblings treated with 1.5 µM OA-NO2 or 100 µM DEM for 6 hours at 4 dpf.  
 
Figure 8 Nitro-fatty acids and cyclopentenone prostaglandins. (A) Chemical structures of 
nitro-fatty acids (OA-NO2 and LNO2) and cyclopentenone prostaglandins (15d-PGJ2 and PGA2). 
(B) Cysteine code hypothesis. OA-NO2 and 15d-PGJ2 share an analogous cysteine code as 
nucleophilic targets and play similar anti-inflammation roles. 
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Supporting Information ⁄Supplementary material 
 
The following Supporting Information can be found in the online version of the article: 
 
Table S1 Generation of stable transgenic lines harboring p3.5gstp1GFP or pT3.5gstp1GFP 
constructs.  
 
Table S2 Peptides identified by MALDI-TOF MS from mouse Keap1 following treatment with 
OA-NO2. 
 
Figure S1 DEM-induced GFP expression in stable transgenic lines. 
 
Figure S2 Constitutive GFP expression in Tg(-3.5gstp1:GFP)it416b larvae at 6 dpf.  
 
Figure S3 Nrf2-induced GFP expression in Tg(-3.5gstp1:GFP)it416b embryos. 
 
Figure S4 The effects of the C288S mutation in Keap1 on the OA-NO2 response. 
 
Movie S1 Real-time monitoring of DEM-induced GFP expression in Tg(-3.5gstp1:GFP)it416b 
larvae. 
 
Movie S2 DEM-induced GFP expression in it567 and its sibling wild-type larvae. 
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